Acquired Venous Thrombosis

Postgraduate Haematology: Fifth Edition

Volumn , Issue , 2007, Pages 900-911

  Hunt, Beverley J ^a   Greaves, Michael ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Acquired venous thrombosis; Antiphospholipid antibodies; Paroxysmal nocturnal haemoglobinuria; Sickle cell disease; Thrombotic thrombocytopenic purpura

Indexed keywords

EID: 77951208315     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987056.ch54     Document Type: Chapter

References (25)

1. Awisati G, Lo Coco F, Mandelli F (2001) Acute promyelocytic leukaemia: clinical and morphological features and prognostic factors. Seminars in Haematology 38: 4-12.
2. Chievitz E, Thiede T (1962) Complications and causes of death in polycythaemia. Acta Medica Scandinavica 172: 513-23.
3. Cortelazzo S, Finazzi G, Ruggeri M et al. (1995) Hydroxyurea for patients with essential thrombocythaemia and a high risk of thrombosis. New England Journal of Medicine 332: 1132-6.
4. Esmon CT (2003) Inflammation and thrombosis. Journal of Thrombosis and Haemostasis 1: 1343-8.
5. Farquharson R, Quenby S, Greaves M (2002) Antiphospholipid syndrome in pregnancy: a controlled treatment trial. Obstetrics and Gynecology 100: 408-11.
6. Gralnick HR, Vail M, McKeown LP et al. (1995) Activated platelets in paroxysmal nocturnal haemoglobinurua. British Journal of Haematology 91: 697-702.
7. Greaves M (1999) Antiphospholipid antibodies and thrombosis. Lancet 353: 1348-53.
8. Greaves M, Machin SJ, Cohen H et al. (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. British Journal of Haematology 109: 704-15.
9. Harrison CN (2002) Current trends in essential thrombocythaemia. British Journal of Haematology 117: 796-808.
10. Hugel B, Socie G, Vu T et al. (1999) Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia. Blood 93: 3451-6.
11. Journeycake JM, Buchanan GR (2003) Thrombotic complications of central venous catheters in children. Current Opinion in Hematology 10: 369-74.
12. Lee AYY, Levine MN, Baker RI et al. (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New England Journal of Medicine 349: 146-53.
13. Packman CH (1998) Pathogenesis and management of paroxysmal nocturnal haemoglobinuria. Blood Reviews 12: 1-11.
14. Pearson TC (2002) The risk of thrombosis in essential thrombocythaemia and polycythaemia vera. Seminars in Oncology 29: 16-21.
15. Peters M, Plaat BEC, ten Cate et al. (1994) Enhanced thrombin generation in children with sickle cell disease. Thrombosis and Haemostasis 71: 169-72.
16. Piccioli A, Vianello F, Prandoni P (2002) Management of thrombosis in patients with haematological malignancies. Current Hematology Reports 1: 79-83.
17. Ploug M, Plesner T, Ronne E et al. (1992) The receptor for urokinase-type plasminogen activator is deficient in peripheral blood leucocytes in patients with paroxysmal nocturnal haemoglobinuria. Blood 79: 1447-55.
18. Prandoni P, Lensing A, Cogo A et al. (1996) The long-term clinical course of acute deep vein thrombosis. Annals of Internal Medicine 125: 1-7.
19. Prandoni P, Bilora F, Marchiori A et al. (2003) An association between atherosclerosis and venous thrombosis. New England Journal of Medicine 348: 1435-41.
20. Rai R, Cohen H, Dave M et al. (1997) Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). British Medical Journal 314: 253-7.
21. Stone S, Hunt BJ, Seed PT et al. (2003) Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy. American Journal of Obstetrics and Gynecology 188: 454-60.
22. Tsai AW, Cushman M, Rosamund WD et al. (2002) Coagulation factors, inflammation markers and venous thromboembolism:the longitudinal investigation of thromboembolism (LITE). American Journal of Medicine 113: 636-42.
23. Vichinski E, Styles LA, Colangelo LH et al. (1997) Acute chest syndrome in sickle cell disease. Blood 89: 1787-92.
24. Warkentin TE (2002) Heparin-induced thrombocytopenia. Current Hematology Reports 1: 63-72.
25. Wood BL, Gibson DF, Tait JF (1996) Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow cytometric measurements and clinical association. Blood 88: 1873-80.